- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Navigating BPCI-A Is a Time to Be Bold
Taking a bold step into the world of bundled payment models can help an organization transform itself, but it could fail.
Organizations that want to change are not the same as organizations that are willing to change. It takes a bold leader to make recommendations that may be new and uncomfortable to the organization. As consultants who analyze complex data on a daily basis, we’re constantly steering our clients to make decisions—including some that may be well outside of their comfort zone. The trend toward more mandatory bundled payment models from CMS will be a forcing function that pushes organizations to make bold decisions and transform their businesses—or fail.
Voluntary models like BPCI-Advanced (BPCI-A), the successor to Bundled Payments for Care Improvement, should be viewed as a sandbox to prepare for this future of mandatory alternative payment models. Now is the time to raise the bar on what’s comfortable — and keep raising it. Now is the time to be bold.
We are passionate about using bundled payment models as innovative solutions for business transformation. Participation can lead to improved quality outcomes and patient/provider satisfaction while lowering costs, and using these models will prepare organizations for the future of value-based care.
Here are 4 things to think about when analyzing whether BPCI-A is right for your organization:
- Evaluate the opportunity and risk areas for your organization: based on analysis of your organization’s data, is this the right program to participate in? If yes, where are the ongoing efforts or teams already in place that you could align with, where this work is a good fit?
- Identify physician leaders who will be critical to this work and begin forming teams around areas of focus where you can gain attention
- Develop your post-acute partnership strategy and identify post-acute pathway risk areas with gaps that must be addressed
- Evaluate staffing and infrastructure needs and identify partners to support your work
Give your organization a leg up in the value-based care environment of tomorrow by moving boldly towards this change today. More mandatory bundled payment models are coming, so it makes sense to the experience you need to effect positive change. BPCI-A can be a great means to decrease readmissions, length of stay, and post-acute utilization while improving internal cost savings, patient/provider satisfaction, and achieving CMS savings. If that sounds good, ask yourself these 3 questions: Do you want to change? Are you willing to change? Are you willing to lead boldly?
Author Information
Darcie Hurteau, MBA, is senior director, DataGen. Tamara Cull, DHA, is senior vice president, Aveus.
About Aveus
The Aveus team offers 20 years of experience in providing strategic consulting, operational and advisory services, value-based program design, integrated care management models, and innovation implementation.
About DataGen
DataGen is an essential partner to healthcare organizations across the country, illustrating the financial implications of payment policy changes and promoting a pragmatic view of how changes will affect revenue and profitability.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
